Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 08-2020 | 08-2019 | 08-2018 | 08-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,142 | 4,424 | 337 | 573 | N/A |
| Receivables | N/A | N/A | 22 | N/A | 0 |
| Other current assets | 0 | 0 | 2 | 0 | 0 |
| TOTAL | $2,337 | $4,443 | $396 | $574 | $N/A |
| Non-Current Assets | |||||
| PPE Net | N/A | 1 | 1 | N/A | 0 |
| Intangibles | 2,039 | 2,039 | 0 | 0 | 0 |
| TOTAL | $2,039 | $2,040 | $1 | $N/A | $N/A |
| Total Assets | $4,376 | $6,483 | $397 | $574 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 501 | 992 | 532 | 30 | 0 |
| Other current liabilities | N/A | 30 | N/A | N/A | 0 |
| TOTAL | $501 | $1,022 | $532 | $29 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $501 | $1,022 | $532 | $29 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 5 | 3 | 2 | 11 | N/A |
| Retained earnings | -9,466 | -4,811 | -2,639 | -295 | N/A |
| Other shareholders' equity | 64 | -10 | -12 | 1 | 0 |
| TOTAL | $3,875 | $5,461 | $-135 | $545 | $N/A |
| Total Liabilities And Equity | $4,376 | $6,483 | $397 | $574 | $0 |